When is a workup for pulmonary hypertension indicated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

When to Initiate a Workup for Pulmonary Hypertension

A workup for pulmonary hypertension is primarily indicated based on echocardiographic findings, presence of symptoms, and risk factors, with right heart catheterization recommended for patients with high probability of pulmonary arterial hypertension. 1

Echocardiographic-Based Indications

The decision to pursue a pulmonary hypertension workup follows a structured approach based on echocardiographic findings:

Low Probability for PAH

  • No additional workup is recommended when echocardiography shows "PH unlikely" and the patient has no symptoms 1
  • Echocardiographic follow-up is recommended when echocardiography shows "PH unlikely" but the patient has symptoms AND risk factors for PAH 1
  • Evaluation of other causes for symptoms is recommended when echocardiography shows "PH unlikely" with symptoms but NO risk factors for PAH 1

Intermediate Probability for PAH

  • Echocardiographic follow-up is recommended when echocardiography shows "PH possible" without symptoms and without risk factors 1
  • Right heart catheterization (RHC) may be considered when echocardiography shows "PH possible" with symptoms and risk factors 1
  • Alternative diagnosis evaluation and echocardiographic follow-up may be considered when echocardiography shows "PH possible" with symptoms but no risk factors; if symptoms are at least moderate, RHC may be considered 1

High Probability for PAH

  • Right heart catheterization is recommended when echocardiography shows "PH likely" with symptoms, regardless of risk factors 1
  • Right heart catheterization should be considered when echocardiography shows "PH likely" without symptoms, regardless of risk factors 1

Symptom-Based Indications

A workup should be initiated when patients present with:

  • Unexplained dyspnea on exertion (most common symptom) 2
  • Unexplained syncope 3
  • Signs of right ventricular dysfunction 2
  • Progression from WHO Functional Class I to higher classes 3

Risk Factor-Based Indications

Patients with the following conditions should be screened for pulmonary hypertension:

  • Systemic sclerosis (annual echocardiography recommended) 4
  • Other connective tissue diseases (when symptoms develop) 4
  • HIV infection 5
  • Portal hypertension/chronic liver disease 5
  • History of anorexigen use (fenfluramine, amphetamines) 5
  • Family history of PAH 6

Components of the Diagnostic Workup

Once indicated, the workup should include:

  • Ventilation/perfusion lung scan - recommended in all patients with unexplained PH to exclude chronic thromboembolic PH (CTEPH) 1
  • Contrast CT angiography - indicated for patients with suspected CTEPH 1
  • Laboratory testing - routine biochemistry, hematology, immunology, and thyroid function tests to identify associated conditions 1
  • Abdominal ultrasound - indicated for screening of portal hypertension 1
  • High-resolution CT - should be considered in all PH patients 1
  • Right heart catheterization - essential for accurate diagnosis and classification 6

Important Considerations

  • Patients with suspected or confirmed PH without confirmed left-sided heart or lung diseases should be referred to a specialist center 6
  • Open or thoracoscopic lung biopsy is not recommended in patients with PAH 1
  • Early diagnosis is critical as targeted treatments are available that can improve morbidity, mortality, and quality of life 6, 5
  • The WHO Functional Classification is an important tool for assessing disease severity and monitoring progression 3

Common Pitfalls to Avoid

  • Delaying workup in patients with progressive unexplained dyspnea 2
  • Failing to perform V/Q scan in patients with suspected PH (may miss treatable CTEPH) 1
  • Initiating treatment without confirming diagnosis with right heart catheterization 6
  • Not referring patients with PAH or CTEPH to specialist centers 6
  • Overlooking screening in high-risk populations, particularly systemic sclerosis patients 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

WHO Functional Classification of Pulmonary Arterial Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pulmonary Hypertension: A Brief Guide for Clinicians.

Mayo Clinic proceedings, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.